Directory

>

Shelley Belouski

avatar

Shelley Belouski

Executive Director, Nonclinical and Bioanalytical Development | Xencor

Pasadena, California, United States

View contact details (it's free)

Shelley Belouski

Summary

Shelley Belouski is an accomplished biopharmaceutical leader with extensive experience in biomedical research and drug development. Currently serving as the Executive Director of Nonclinical and Bioanalytical Development at Xencor, she specializes in the scientific design and management of drug discovery and preclinical programs, particularly for large molecule immunomodulatory drugs targeting oncology and autoimmunity. With a strong operational and scientific leadership background, she has spearheaded international expansions for laboratory capabilities across multiple countries. Shelley holds a Doctor of Philosophy from UT Southwestern Medical Center and is a Diplomate of the American Board of Toxicology. Her expertise encompasses a wide range of areas including immunology, molecular biology, and clinical development, making her a key player in the biotechnology sector. She is also a full member of prestigious organizations such as the Society of Toxicology and the American College of Toxicology, reflecting her commitment to advancing the field.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Industry-specific interests

Emerging Technologies

Leadership Development

Organisational experience

Corporate Experience

Non-Profit Experience

Shelley Belouski

Work Experience

company logo

Executive Director, Nonclinical and Bioanalytical Development at

Xencor, Inc.

Present

company logo

Executive Director, Nonclinical & Bioanalytical Development at

Xencor

January 2015 - Present

company logo

Senior Director, Preclinical Sciences And Quality Control at

Xencor, Inc.

January 1970 - Present

💼

Director, Medical Sciences at

Amgen

January 1970 - January 1970

💼

Research Scientist at

UT SOUTHWESTERN MEDICAL CENTER

January 1970 - January 1970

company logo

Associate Scientist, Collaborations at

Abgenix

Logos provided by Logo.dev

Shelley Belouski

Education

Southern Methodist University

January 1970 - January 1970

The University of Sheffield

January 1970 - January 1970

The University of Texas at Arlington, Bachelors

January 1970 - January 1970

The University of Texas Southwestern Medical School, Doctorates

January 1970 - January 1970

UT Southwestern Medical Center, Doctorates

University of Sheffield

Frequently Asked Questions about Shelley Belouski

What is Shelley Belouski email address?

Shelley Belouski's primary email address is *********@xencor.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Shelley Belouski work for?

Shelley Belouski is a Executive Director, Nonclinical and Bioanalytical Development at Xencor, a company specializing in Commercial physical research.

Where Shelley Belouski graduated from?

Shelley Belouski holds a degree in from Southern Methodist University.

How can I directly contact Shelley Belouski?

To contact Shelley Belouski directly, you can use the email address *********@xencor.com. Complete contact information is available upon registration with Muraena.

Who is Shelley Belouski?

Shelley Belouski is an accomplished biopharmaceutical leader with extensive experience in biomedical research and drug development. Currently serving as the Executive Director of Nonclinical and Bioanalytical Development at Xencor, she specializes in the scientific design and management of drug discovery and preclinical programs, particularly for large molecule immunomodulatory drugs targeting oncology and autoimmunity. With a strong operational and scientific leadership background, she has spearheaded international expansions for laboratory capabilities across multiple countries. Shelley holds a Doctor of Philosophy from UT Southwestern Medical Center and is a Diplomate of the American Board of Toxicology. Her expertise encompasses a wide range of areas including immunology, molecular biology, and clinical development, making her a key player in the biotechnology sector. She is also a full member of prestigious organizations such as the Society of Toxicology and the American College of Toxicology, reflecting her commitment to advancing the field.

Shelley`s contact details

mail

*********@xencor.com

********@amgen.com

****************@utsouthwestern.edu

*********@bing.com

****************@codexis.com

Colleagues

avatar
Sophie Visonneau

Vice President, Head of Clinical Operations

avatar
Robin Silva

Patent Attorney (retired but consulting for Xencor)

avatar
Kirk Rosemark

Sr. Vice President Regulatory Affairs and Quality Assurance

avatar
Eric Kowack

Vice President, Program Leadership and Strategic Alliances

avatar
Julie Casciani

Executive Director, Human Resources

avatar
Bart Burington

Vice President, Biometrics

Kathleen Walker

Executive Director Regulatory CMC

avatar
Charles Reichel

Executive Director, CMC Operations – Drug Product and Supply Chain

avatar
Frances Rena Bahjat

VP Discovery Biology and Pharmacology

View Contact details (it's free)
Request Profile Removal